- Home
- ANIK vs FATE Comparison
ANIK vs FATE Comparison
Compare ANIK & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIK
- FATE
- Stock Information
- Founded
- ANIK 1983
- FATE 2007
- Country
- ANIK United States
- FATE United States
- Employees
- ANIK N/A
- FATE N/A
- Industry
- ANIK Medical/Dental Instruments
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ANIK Health Care
- FATE Health Care
- Exchange
- ANIK Nasdaq
- FATE Nasdaq
- Market Cap
- ANIK 133.1M
- FATE 116.5M
- IPO Year
- ANIK 1993
- FATE 2013
- Fundamental
- Price
- ANIK $9.82
- FATE $1.54
- Analyst Decision
- ANIK Buy
- FATE Hold
- Analyst Count
- ANIK 1
- FATE 6
- Target Price
- ANIK $15.00
- FATE $3.30
- AVG Volume (30 Days)
- ANIK 97.4K
- FATE 3.1M
- Earning Date
- ANIK 10-31-2025
- FATE 11-11-2025
- Dividend Yield
- ANIK N/A
- FATE N/A
- EPS Growth
- ANIK N/A
- FATE N/A
- EPS
- ANIK N/A
- FATE N/A
- Revenue
- ANIK $114,548,000.00
- FATE $8,470,000.00
- Revenue This Year
- ANIK N/A
- FATE N/A
- Revenue Next Year
- ANIK $4.57
- FATE N/A
- P/E Ratio
- ANIK N/A
- FATE N/A
- Revenue Growth
- ANIK 16.52
- FATE N/A
- 52 Week Low
- ANIK $7.87
- FATE $0.66
- 52 Week High
- ANIK $25.00
- FATE $3.50
- Technical
- Relative Strength Index (RSI)
- ANIK 62.94
- FATE 62.87
- Support Level
- ANIK $8.67
- FATE $1.42
- Resistance Level
- ANIK $9.80
- FATE $1.58
- Average True Range (ATR)
- ANIK 0.31
- FATE 0.15
- MACD
- ANIK 0.07
- FATE -0.00
- Stochastic Oscillator
- ANIK 97.87
- FATE 69.23
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.